Can a common sedative prevent Post-Surgery delirium in elderly cancer patients?

NCT ID NCT03012984

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at whether adding dexmedetomidine to standard morphine pain relief after cancer surgery could lower the chance of delirium (sudden confusion) in patients aged 65 and older. A total of 1500 participants were randomly assigned to receive either morphine alone or morphine plus dexmedetomidine for three days after surgery. The main goal was to see if the combination reduced delirium within the first five days after the operation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
dexmedetomidine
What this could lead to
If it works, this could offer a simple way to lower the risk of confusion and delirium after cancer surgery in older adults.
What could go wrong
This is a completed trial, but results are not yet widely confirmed. The effect may be small or not apply to all patients. Dexmedetomidine can cause low blood pressure or slow heart rate.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANALGESIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

agnosia delirium pain agnosia Postoperative Complications

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Affiliated Hospital of Hebei University

    Baoding, Hebei, 050031, China

  • Chongqing University Fuling Hospital

    Chongqing, Chongqing Municipality, 408099, China

  • Guizhou Provincial People's Hospital

    Guiyang, Guizhou, 550002, China

  • Peking University First Hospital

    Beijing, Beijing Municipality, 100034, China

  • Peking University International Hospital

    Beijing, Beijing Municipality, 102206, China

  • Qingdao Municipal Hospital

    Qingdao, Shandong, 266011, China

  • Shanxi Provincial Cancer Hospital

    Taiyuan, Shanxi, 030013, China

  • The Second Affiliated Hospital of Air Force Medical University

    Xi'an, Shaanxi, 710038, China

  • The Third Central Hospital of Tianjin

    Tianjin, Tianjin Municipality, 300170, China

  • The Third Xiangya Hospital of Central South University

    Changsha, Hunan, 410013, China

  • Tianjin Hospital of ITCWM-Nankai Hospital

    Tianjin, Tianjin Municipality, 300100, China

  • Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Beijing, Beijing Municipality, 100091, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.